Anatomic T2/FLAIR sequences are the gold standard in the diagnostic and monitoring process of non-enhancing gliomas but do not provide accurate information about the underlying metabolic activity of the tumor. In this work, we investigated the combined use of 2-hydroxyglutarate (2HG) magnetic resonance spectroscopic imaging (MRSI) and a novel three-compartment diffusion MRI method (Linear Multi-Scale Model) to characterize isocitrate dehydrogenase-mutant gliomas, and found that high 2HG levels correlated with decreased restricted diffusion.
This abstract and the presentation materials are available to members only; a login is required.